About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
Radiolabelled Small Molecule Inhibitors of PSMA: A Promising New Therapeutic Strategy for Prostate Cancer
By
John Violet
2 Videos
94 views
September 29, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
19:22
Janssen Oncology
Doc Talk Podcast
Feat.
J. Hamilton,
M. Fabrizio,
M. Taha
Featured Video
20:59
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Related Content
AUTOPLAY
ON
25:23
Houston Methodist Hospital
Whole-Body MRI: Past, Present, and Future
Feat.
N. Gupta
05:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …
Feat.
S. Tagawa
25:33
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…
Feat.
J. Berchuck,
A. Choudhury
10:13
Judd Moul
Treatment Intensification in Advanced Prostate Cancer
34:43
OncoAlert
Year in Review: Therapeutic Advances in Prostate Cancer
Feat.
N. Agarwal
41:08
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Radiation Oncology: Basic Principles and Updates
Feat.
J. Chen
17:23
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "PSMA-PET Imaging Case Studies and Sequenc…
Feat.
P. Tran
69:15
Matthew Kurian
Lutetium-177 in the Treatment of Metastatic Castrate-Resistant Prost…
Feat.
J. Brown
10:48
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "[177 Lu]Lu-PSMA-617 in Taxane-Naïve Patien…
Feat.
O. Sartor
04:13
Karine Tawagi
Diagnostic and Therapeutic Updates in mCRPC: Radioligand Therapy
23:03
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ASCO® GU 2024
Feat.
J. Berchuck,
A. Choudhury
08:03
UCLA Health
Managing Advanced Prostate Cancer Pts in Urology Clinics and When to…
Feat.
I. Garraway
11:35
PROSCA & BLADDR 2023
Nodal Recurrences in Prostate Cancer: What Is the Optimal Approach?
Feat.
P. Ost
06:14
Robert Dreicer
Current Trends in Treatment Landscape for mCRPC: Where Does Cabazita…
28:34
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ESMO 2023
Feat.
M. Serzan,
M. Taplin
12:12
PROSCA & BLADDR 2023
When Is RT Indicated for Prostate Cancer and Should We Add ADT?
Feat.
P. Sargos
30:12
PROSCA & BLADDR 2023
The Role of PSMA-PET/CT in Primary Staging, for Follow-Up After Radi…
Feat.
K. Goffin
30:29
Icahn School of Medicine at Mount Sinai
Mount Sinai School of Medicine Prostate Cancer Updates
Feat.
C. Tsao
14:13
PROSCA & BLADDR 2022
A Medical Oncologist’s Perspective on Therapy Development in Prostat…
Feat.
E. Efstathiou
18:42
International Urology Cancer Summit - IUCS
Theragnostics in Metastatic Prostate Cancer: Diagnosis and Treatment
Feat.
G. Gnanasegaran
